LAVIE BIO Trademark
Serial Number: 79366259 • Registration: 7312615
LAVIE BIO is a trademark filed by
LAVIE BIO LTD
on January 12, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Kevin D. McCarthy Roach Brown McCarthy & Gruber, P.C.
424 Main Street
1920 Liberty Building
Buffalo
NY 14202
Trademark Details
Filing Date
January 12, 2023
Registration Date
February 27, 2024
Published for Opposition
December 12, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 20, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 3, 2024 FICS
FINAL DISPOSITION PROCESSED
Jul 3, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2024 FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 27, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 12, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Dec 11, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 22, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2023 NONP
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 10, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 4, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2023 REPR